Evidence map›Paper›PMID 30623063›Full record

ArticleHealth science reports2018

Producing an evidence-based treatment information website in partnership with people affected by multiple sclerosis.

Anneliese J Synnot, Melanie Hawkins, Bronwen A Merner, Michael P Summers, Graziella Filippini, Richard H Osborne, Sue D P Shapland, Catherine L Cherry, Rwth Stuckey, Catherine A Milne and 3 more

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Anneliese J SynnotCentre for Health Communication and Participation, School of Psychology and Public Health La Trobe University Melbourne Australia.ORCID 0000-0002-4008-4208
Melanie HawkinsHealth Systems Improvement Unit, Centre for Population Health Research, School of Health and Social Development Deakin University Geelong Australia.
Bronwen A MernerCentre for Health Communication and Participation, School of Psychology and Public Health La Trobe University Melbourne Australia.ORCID 0000-0001-9263-362X
Michael P SummersCentre for Health Communication and Participation, School of Psychology and Public Health La Trobe University Melbourne Australia.
Graziella FilippiniCochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Review Group, Scientific Direction IRCCS Foundation Neurological Institute Carlo Besta Milan Italy.
Richard H OsborneHealth Systems Improvement Unit, Centre for Population Health Research, School of Health and Social Development Deakin University Geelong Australia.
Sue D P ShaplandMS Australia Perth Australia.
Catherine L CherryBurnet Institute, Department of Infectious Diseases The Alfred Hospital and Monash University Melbourne Australia.
Rwth StuckeyCentre for Ergonomics and Human Factors, School of Psychology and Public Health La Trobe University Melbourne Australia.
Catherine A MilneCentre for Values, Ethics and Law in Medicine University of Sydney Sydney New South Wales Australia.
Paola MosconiLaboratory for Medical Research and Consumer Involvement, Department of Public Health IRCCS Istituto di Ricerche Farmacologiche Mario Negri Milan Italy.
Cinzia ColomboLaboratory for Medical Research and Consumer Involvement, Department of Public Health IRCCS Istituto di Ricerche Farmacologiche Mario Negri Milan Italy.
Sophie J HillCentre for Health Communication and Participation, School of Psychology and Public Health La Trobe University Melbourne Australia.ORCID 0000-0002-1715-5338
La Trobe University · AUDeakin University · AUMario Negri Institute for Pharmacological Research · ITBurnet Institute · AUMSD (Australia) · AUMultiple Sclerosis Foundation · USThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsIn earlier work, we identified that people affected by multiple sclerosis (MS) can have difficulty finding online treatment information that is up to date, trustworthy, understandable, and applicable to personal circumstances, but does not provoke confusion or negative emotional consequences. The objective was to develop online consumer summaries of MS treatment evidence (derived from Cochrane Reviews) that respond to identified treatment information needs of people affected by MS.

methodsA 2-phase mixed-methods project, conducted in partnership with consumers and an MS organisation. Phase 1 included review panels with consumers (Australians affected by MS) and health professionals to test paper-based treatment summaries before development, and pilot testing of the website. Phase 2 involved an online survey after website launch.

resultsEighty-three participants (85% affected by MS) took part. Phase 1 participants strongly endorsed key review summary components, including layering information, and additional sections to aid personal applicability. Participants additionally suggested questions for health professionals. Participants across both phases were receptive to the idea of being provided with Cochrane Review summaries online but were seeking other types of evidence and information, such as personal experiences and the latest experimental treatments, which could not be provided. While the small survey sample size (n = 58) limits application of the results to a broader population, the website was viewed favourably, as a useful, understandable, and trustworthy information source.

conclusionWe describe a partnership approach to developing online evidence-based treatment information, underpinned by an in-depth understanding of consumers' information needs.

Indexed as

Cochraneconsumer participationevidence‐based treatment informationhealth educationmultiple sclerosispatient and public involvementsystematic review

Identifiers

PMID30623063
PMCPMC6266475
OpenAlexW2791958710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.